Foundation Fighting Blindness

Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

Episodes

Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg

January 9, 2026 • 47 mins
Josh Steinberg and his father, Jon, talk with host Ben Shaberman about their close-knit family's journey with Josh's vision loss and eventual diagnosis of retinitis pigmentosa, as well as their volunteer leadership roles in driving the Foundation's mission. Jon is Chair of the Foundation's Science Committee and Vice Chair for Science on the Board. Josh is the former Chair of the Strategic Council and also a Board director.
Mark as Played

Eye on the Cure Podcast | Episode 97: Lindsey Rambo

December 19, 2025 • 39 mins
Lindsey Rambo, a special education teaching assistant, mom, and wife, talks to host Ben Shaberman about her journey with Leber congenital amaurosis 5 (LCA5), participation in Opus Genetics' LCA5 gene therapy clinical trial, and her appearance on Good Morning America to tell her story about meaningful vision improvements. 
Mark as Played

Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy

December 18, 2025 • 2 mins
The company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.
Mark as Played

Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara

December 5, 2025 • 43 mins
Dr. Deniz Dalkara, a research director at INSERM in France, talks to hose Ben Shaberman about her emerging gene-agnostic, gene therapy designed to restore cone-mediated vision in people with advanced retinitis pigmentosa. Known as SPVN20 and clinically developed by SparingVision, the treatment recently moved into a clinical trial in Europe. Dr. Dakara also discusses her earlier work in retinal gene and optogenetic therapy developme...
Mark as Played

Belite Bio to Seek FDA Approval for its Stargardt Disease Drug

December 2, 2025 • 3 mins
Tinlarebant slowed disease progression by 36 percent in the Dragon Phase 3 clinical trial.
Mark as Played

Opus Genetics Launches Gene Therapy Clinical Trial for Best Disease

November 14, 2025 • 2 mins
The Foundation funded preclinical studies for the approach and launched Opus.
Mark as Played

Eye on the Cure Podcast | Episode 95: Greta Streimikyte

November 14, 2025 • 20 mins
Greta Streimikyte, a blind para-athletic running champion from Ireland, talks to host Ben Shaberman about growing up with substantial vision loss from retinopathy of prematurity and her competitive running career. Greta has won gold in the women's 1500 meters at the 2018 and 2021 European Para Athletic Championships and is a three-time Paralympian.
Mark as Played

Eye on the Cure Podcast | Episode 94: Dr. Victoria Claire

October 31, 2025 • 53 mins
October 31, 2025. Dr. Victoria Claire has commissioned more than 200 sculptures, received an honorary doctorate, and is pursuing a PhD. She talks with host Ben Shaberman about her journey with retinitis pigmentosa, and how blindness has provided her with new and profound insights into herself and perceiving the world. Visitors to her current exhibition, "The Sense of Sculpture" (Oct. 18 - Nov. 1) at The Art House in Wakefield, Engl...
Mark as Played

SparingVision Launches Clinical Trial for Therapy to Re-Activate Dormant Cones in Advanced RP

October 28, 2025 • 4 mins
The approach may provide better visual acuity than current optogenetic therapies in clinical trials.
Mark as Played

Eye on the Cure Podcast | Episode 93: Sam Seavey

October 17, 2025 • 41 mins
October 17, 2025. Sam Seavey, founder and host of the acclaimed The Blind Life YouTube channel, talks with host Ben Shaberman about his journey with Stargardt disease, some of the latest assistive technologies, and how the 900+ videos on The Blind Life can be informative and helpful for people with low vision.
Mark as Played

Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial

October 2, 2025 • 3 mins
The emerging therapy improved vision for some participants in an earlier clinical trial.
Mark as Played

Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy

September 30, 2025 • 4 mins
Durable vision improvements were also observed out to 18 months for previously dosed adult patients in the trial.
Mark as Played

Eye on the Cure Podcast | Episode 92: Lance Baldo, MD

September 26, 2025 • 30 mins
Lance Baldo, MD, CEO at Beacon Therapeutics, talks to host Ben Shaberman about his company's fully enrolled Phase 3 VISTA clinical trial for laru-zova, a gene therapy for X-linked retinitis pigmentosa (RPGR mutations) that's showed promising results in earlier trials. They also discuss Beacon's forthcoming clinical trial for its dry age-related macular degeneration gene therapy.
Mark as Played

Agnes Gund – Renowned Philanthropist, Social Justice Champion, and Art Patron – Passes Away

September 22, 2025 • 2 mins
The documentary “Aggie: An Incredible Story of Art and Justice” chronicles her story.
Mark as Played

Nacuity’s Antioxidative Therapy NACA Performs Encouragingly in Phase 1/2 Clinical Trial

September 12, 2025 • 3 mins
NACA is a gene-agnostic, oral medication designed to preserve vision in people with retinitis pigmentosa and Usher syndrome.
Mark as Played

Eye on the Cure Podcast | Episode 91: Dr. George Magrath

September 5, 2025 • 22 mins
September 5, 2025. Dr. George Magrath, CEO of Opus Genetics, talks with host Ben Shaberman about the company's evolution and progress in clinically developing gene therapies for several inherited retinal diseases including those caused by mutations in the genes: LCA5, BEST1, RHO, RDH12, MERTK, NMNAT1, and CNGB1.
Mark as Played

Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy

August 22, 2025 • 2 mins
The Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.
Mark as Played

jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy

August 20, 2025 • 3 mins
The trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.
Mark as Played

Eye on the Cure Podcast | Episode 90: Dr. Christina Ohnsman

August 8, 2025 • 27 mins
August 8, 2025. Dr. Christina Ohnsman talks to host Ben Shaberman about Tern Therapeutics, a start-up company she co-founded to develop gene therapies for Batten disease and potentially other conditions. Dr. Ohnsman reviews early results for a Batten disease (CLN2) retinal gene therapy clinical trial. She also reflects on her previous work as a pediatric ophthalmologist and roles with Spark Therapeutics and Regenxbio.
Mark as Played

Wet AMD Treatment Susvimo Preserves Vision for Five Years in Phase 3 Clinical Trial

August 6, 2025 • 3 mins
Susvimo is an FDA-approved treatment that continuously delivers drug through a tiny, implanted capsule
Mark as Played

Popular Podcasts

    Dateline NBC

    Dateline NBC

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

    Stuff You Should Know

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

    The Breakfast Club

    The Breakfast Club

    The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!

    Crime Junkie

    Crime Junkie

    Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by Audiochuck Media Company.

    Two Guys, Five Rings: Matt, Bowen & The Olympics

    Two Guys, Five Rings: Matt, Bowen & The Olympics

    Two Guys (Bowen Yang and Matt Rogers). Five Rings (you know, from the Olympics logo). One essential podcast for the 2026 Milan-Cortina Winter Olympics. Bowen Yang (SNL, Wicked) and Matt Rogers (Palm Royale, No Good Deed) of Las Culturistas are back for a second season of Two Guys, Five Rings, a collaboration with NBC Sports and iHeartRadio. In this 15-episode event, Bowen and Matt discuss the top storylines, obsess over Italian culture, and find out what really goes on in the Olympic Village.

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

Explore

iHeart

Live Radio

Podcasts

Artist Radio

Exclusives

News

Features

Events

Contests

Photos

Information

About

Advertise

Blog

Brand Guidelines

Contest Guidelines

Subscription Offers

Jobs

Get the App

Automotive

Home

Mobile

Wearables

© 2026 iHeartMedia, Inc.